Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: A single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 3, 2003, Pages 709-716

  Videtic, Gregory M M ^a   Truong, Pauline T ^b   Dar, A Rashid ^c   Yu, Edward W ^c   Stitt, Larry W ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BC Cancer Agy Vancouver Isl C   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Concurrent chemoradiation; Fractionation; Limited stage; Small cell lung cancer; Treatment time

Indexed keywords

CELLS; PATIENT TREATMENT; TOXICITY; TUMORS;

LUNG CANCERS;

ONCOLOGY;

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANADA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DEHYDRATION; DYSPHAGIA; ESOPHAGITIS; EXPERIENCE; FEMALE; FEVER; FRACTIONATION; HUMAN; INSTITUTIONAL CARE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MODEL; NAUSEA; NEUTROPENIA; NEUTROPENIC FEVER; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; SEPSIS; SKULL IRRADIATION; TARGET ORGAN; THORAX; THROMBOCYTOPENIA; TOXICITY; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 0141571152     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00635-7     Document Type: Article

References (22)

1. Sherman C.A., Lima C.M.R., Turrisi A.T. III. Limited small-cell lung cancer A potentially curable disease . Oncology (Huntingt). 14:2000;1395-1403.
2. Murray N. Small-cell lung cancer at the millennium Radiotherapy innovations improve survival while new chemotherapy treatments remain unproven . Clin Lung Cancer. 1:2000;181-190.
3. De Ruysscher D., Vansteenkiste J. Chest radiotherapy in limited-stage small cell lung cancer Facts, questions, prospects . Radiother Oncol. 55:2000;1-9.
4. Perry M.C., Eaton W.L., Propert K.J., et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 316:1987;912-918.
5. Murray N., Coy P., Pater J.L., et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol. 11:1993;336-344.
6. Work E., Nielsen O., Bentzen S., et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol. 15:1997;3030-3037.
7. Turrisi A.T. III, Kyungmann K., Blum R., et al. Twice-daily compare with one-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 340:1999;265-271.
8. Takada M., Fukuoka M., Kawahara K., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer Results of the Japan Clinical Oncology study 9104 . J Clin Oncol. 20:2002;3054-3060.
9. Bonner J.A., Sloan J.A., Shanahan T.G., et al. Phase III comparison of twice-daily split-course irradiation versus one-daily radiation for patients with limited stage small-cell lung cancer. J Clin Oncol. 17:1999;2681-2691.
10. Jeremic B., Shibamato Y., Acimovic L., et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited SCLC A randomized study . J Clin Oncol. 15:1997;893-900.
11. Abadir R., Orton C. Radiotherapy for small-cell lung cancer. N Engl J Med. 340:1999;2002-2003.
12. Murray N., Hadzic E., Shah A., et al. Alternating chemotherapy and thoracic irradiation with concurrent cisplatin-etoposide for limited stage SCLC. [Abstract] Proc Am Soc Clin Oncol. 3:1984;321a.
13. Turrisi A.T. III, Withers H.R. Radiotherapy in limited small cell lung cancer Fractionation and timing of modalities . Semin Radiat Oncol. 5:1995;55-60.
14. Withers H.R. Biological basis of radiation therapy. Perez C.A., Brady L.W. Principles and practices of radiation oncology. 2nd ed:1992;64-96 JB Lippincott, Philadelphia.
15. Movsas B. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. Oncology (Huntingt). 15:2001;1549-1557.
16. Emami B., Perez C.A. Lung. Perez C.A., Brady L.W. Principles and practices of radiation oncology. 2nd ed:1992;806-836 JB Lippincott, Philadelphia.
17. Videtic G.M.M., Fung K., Tomiak A.T., et al. Using treatment interruptions to palliate the toxicity form concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. Lung Cancer. 33:2001;249-258.
18. Hall E.J. Radiobiology for the radiologist. 4th ed:1994;211-230 JB Lippincott, Philadelphia.
19. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 49:2001;23-33.
20. Nguyen L.N., Komaki R., Allen P., et al. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis A retrospective review . Int J Radiat Oncol Biol Phys. 44:1999;1053-1056.
21. Curran W. Jr, Scott C., Langer C., et al. Phase III comparison of sequential vs concurrent chemoradiation for patients (pts) with unresected stage III non-small cell lung cancer (NSCLC) Initial report of Radiation Therapy Oncology Group (RTOG) 9410 . [Abstract] Proc Am Soc Clin Oncol. 19:2000;484a.
22. Cheung P.C., Yeung L.T., Basrur V., et al. Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 54:2002;1014-1023.